​

Caribou Biosciences (CRBU) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChart

CRBU Stock Forecast

Caribou Biosciences (CRBU) stock forecast, based on 3 Wall Street analysts, predicts a 12-month average price target of $3.00, with a high of $3.00 and a low of $3.00. This represents a 123.88% increase from the last price of $1.34.

$1 $2 $3 $4 $5 $6 $7 $8 High: $3 Avg: $3 Low: $3 Last Closed Price: $1.34

CRBU Stock Rating

Caribou Biosciences stock's rating consensus is Buy, based on 3 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 3 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 3 0 3 Strong Sell Sell Hold Buy Strong Buy

CRBU Forecast vs Benchmarks

TypeNameUpside
StockCaribou Biosciences123.88%
SectorHealthcare Stocks 25.20%
IndustryBiotech Stocks 63.35%

Price Target Trends

1M3M12M
# Anlaysts--1
Avg Price Target--$3.00
Last Closing Price$1.34$1.34$1.34
Upside/Downside--123.88%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 25252--9
Dec, 24252--9
Nov, 24352--10
Oct, 24352--10
Sep, 24352--10
Latest Price Target by Analysts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jun 03, 2024Liisa BaykoEvercore ISI$3.00$2.884.17%123.88%
Latest Upgrade/Downgrade by Analysts
DateCompanyPrevious RatingNew RatingRating Change
Sep 04, 2024H.C. WainwrightBuyBuyhold
Aug 14, 2024RBC CapitalBuyBuyhold
Jul 17, 2024H.C. WainwrightBuyBuyhold
Jun 04, 2024H.C. WainwrightBuyBuyhold
Jun 03, 2024CitigroupBuyBuyhold
May 16, 2024RBC CapitalBuyBuyhold
Feb 18, 2022RBC CapitalOutperforminitialise
Nov 30, 2021H.C. WainwrightBuyinitialise

Financial Forecast

EPS Forecast

Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.11$-1.64$-1.38-----
Avg Forecast$-2.12$-1.69$-1.37$-1.66$-1.86$-1.95$-2.39$-1.17
High Forecast$-3.07$-2.19$-1.47$-1.74$-3.04$-2.68$-3.80$-1.51
Low Forecast$-0.97$-1.42$-1.19$-1.50$-1.37$-1.32$-1.19$-0.98
Surprise %-47.64%-2.96%0.73%-----

Revenue Forecast

$0 $90M $180M $270M $360M $450M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$9.60M$13.85M$34.48M-----
Avg Forecast$10.94M$12.43M$34.90M$10.26M$10.14M$28.18M$51.75M$330.94M
High Forecast$6.39M$10.90M$33.29M$8.25M$8.90M$24.72M$45.40M$290.30M
Low Forecast$14.69M$15.27M$38.69M$11.93M$12.45M$34.60M$63.56M$406.41M
Surprise %-12.27%11.42%-1.23%-----

Net Income Forecast

$-300M $-250M $-200M $-150M $-100M $-50M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-66.92M$-99.42M$-102.07M-----
Avg Forecast$-156.59M$-124.81M$-102.07M$-119.42M$-195.12M$-147.87M$-267.57M$-85.99M
High Forecast$-226.35M$-161.81M$-108.59M$-128.37M$-224.34M$-198.11M$-280.47M$-111.48M
Low Forecast$-71.93M$-104.88M$-87.62M$-110.46M$-100.99M$-97.63M$-87.83M$-72.26M
Surprise %-57.26%-20.34%------

CRBU Forecast FAQ

Is Caribou Biosciences stock a buy?

Caribou Biosciences stock has a consensus rating of Buy, based on 3 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 3 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Caribou Biosciences is a favorable investment for most analysts.

What is Caribou Biosciences's price target?

Caribou Biosciences's price target, set by 3 Wall Street analysts, averages $3 over the next 12 months. The price target range spans from $3 at the low end to $3 at the high end, suggesting a potential 123.88% change from the previous close price of $1.34.

How does Caribou Biosciences stock forecast compare to the average forecast of its sector, industry, and investment themes?

Caribou Biosciences stock forecast shows a 123.88% upside, outperforming the average forecast for the healthcare stocks sector (25.20%) and outperforming the biotech stocks industry (63.35%).

What is the breakdown of analyst ratings for Caribou Biosciences over the past three months?

  • January 2025: 22.22% Strong Buy, 55.56% Buy, 22.22% Hold, 0% Sell, 0% Strong Sell.
  • December 2024: 22.22% Strong Buy, 55.56% Buy, 22.22% Hold, 0% Sell, 0% Strong Sell.
  • November 2024: 30.00% Strong Buy, 50.00% Buy, 20.00% Hold, 0% Sell, 0% Strong Sell.

What is Caribou Biosciences’s EPS forecast?

Caribou Biosciences's average annual EPS forecast for its fiscal year ending in December is -1.66 for 2024, a 20.29% increase from the reported $-1.38 in 2023. The prediction for 2025 is $-1.86, $-1.95 for 2026, $-2.39 for 2027, and $-1.17 for 2028.

What is Caribou Biosciences’s revenue forecast?

Caribou Biosciences's average annual revenue forecast for its fiscal year ending in December is $10.26M for 2024, a -70.24% decrease from the reported $34.48M in 2023. The forecast for 2025 is $10.14M, $28.18M for 2026, $51.75M for 2027, and $330.94M for 2028.

What is Caribou Biosciences’s net income forecast?

For its fiscal year ending in December, Caribou Biosciences's average annual net income forecast is $-119M for 2024, reflecting an 16.99% increase from the reported $-102M in 2023. The projection for 2025 is $-195M, $-148M for 2026, $-268M for 2027, and $-85.986M for 2028.